Temsirolimus plus an anti-EGFR inhibitor had a synergistic anticancer effect.316 Both temsirolimus and RAD001 treatment showed significant tumor shrinkage, and mTOR activation was inhibited in HPV-positive oral and cervical squamous cell carcinoma (SCC) xenografts. Here, MTOR is linked to neoplasm.